Innogenetics launches autoimmune disease test:
This article was originally published in Clinica
Innogenetics has launched its INNO-LIA ANA test for detecting autoimmune rheumatological disease. Autoimmune disorders, in which the body mistakenly attacks itself, are responsible for a large number of rheumatological diseases. The Belgian company estimates that in Europe alone autoimmune diseases affect as many as three million people, mostly women.
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.